[11C]PIB binding in Parkinson's disease dementia
Walter Maetzler(Centre Hospitalier Universitaire de Lille), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Gerhard W. Eschweiler(University Children's Hospital Tübingen), Michel Mittelbronn(Centre Hospitalier de Luxembourg), Inga Liepelt(Hertie Institute for Clinical Brain Research), Christoph Solbach(University of Tübingen), Alexandra Gaenslen(German Center for Neurodegenerative Diseases), Thomas Gasser(Hertie Institute for Clinical Brain Research), Roland Bares(Universitätsklinikum Tübingen), Matthias Reimold(The University of Sydney), Michael Uebele(University of Tübingen), Thomas Leyhe(University of Tübingen), Katherine J. Schweitzer, Hans‐Jürgen Machulla(University of Tübingen), Gerald Reischl(University of Tübingen)
Cited by 133
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k